Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression

Abstract Background The catenin beta 1 gene (CTNNB1) plays a crucial role in the malignant progression of various cancers. Recent studies have suggested that CTNNB1 hyperactivation is closely related to the occurrence and development of bladder cancer (BCa). As a member of the deubiquitinating enzym...

Full description

Bibliographic Details
Main Authors: Tao Liu, Meng-Qi Fan, Xiao-Xiao Xie, Qi-Peng Shu, Xue-Hua Du, Lin-Zhi Qi, Xiao-Dong Zhang, Ming-Hui Zhang, Guang Shan, Run-Lei Du, Shang-Ze Li
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-023-04311-3
_version_ 1797556787089506304
author Tao Liu
Meng-Qi Fan
Xiao-Xiao Xie
Qi-Peng Shu
Xue-Hua Du
Lin-Zhi Qi
Xiao-Dong Zhang
Ming-Hui Zhang
Guang Shan
Run-Lei Du
Shang-Ze Li
author_facet Tao Liu
Meng-Qi Fan
Xiao-Xiao Xie
Qi-Peng Shu
Xue-Hua Du
Lin-Zhi Qi
Xiao-Dong Zhang
Ming-Hui Zhang
Guang Shan
Run-Lei Du
Shang-Ze Li
author_sort Tao Liu
collection DOAJ
description Abstract Background The catenin beta 1 gene (CTNNB1) plays a crucial role in the malignant progression of various cancers. Recent studies have suggested that CTNNB1 hyperactivation is closely related to the occurrence and development of bladder cancer (BCa). As a member of the deubiquitinating enzyme (DUB) family, ubiquitin C-terminal hydrolase L3 (UCHL3) is abnormally expressed in various cancers. In this study, we discovered that UCHL3 is a novel oncogene in bladder cancer, suggesting it is a promising target against bladder cancer. Methods We utilized CRISPR‒Cas9 technology to construct cell lines with UCHL3 stably overexpressed or knocked out. The successful overexpression or knockout of UCHL3 was determined using Western blotting. Then, we performed CCK-8, colony formation, soft agar and Transwell migration assays to determine the impact of the UCHL3 gene on cell phenotype. RNA-seq was performed with UCHL3-depleted T24 cells (established via CRISPR–Cas9-mediated genomic editing). We analyzed differences in WNT pathway gene expression in wild-type and UCHL3-deficient T24 cell lines using a heatmap and by gene set enrichment analysis (GSEA). Then, we validated the effect of UCHL3 on the Wnt pathway using a dual fluorescence reporter. We then analyzed the underlying mechanisms involved using Western blots, co-IP, and immunofluorescence results. We also conducted nude mouse tumor formation experiments. Moreover, conditional UCHL3-knockout mice and bladder cancer model mice were established for research. Results We found that the overexpression of UCHL3 boosted bladder cancer cell proliferation, invasion and migration, while the depletion of UCHL3 in bladder cancer cells delayed tumor tumorigenesis in vitro and in vivo. UCHL3 was highly associated with the Wnt signaling pathway and triggered the activation of the Wnt signaling pathway, which showed that its functions depend on its deubiquitination activity. Notably, Uchl3-deficient mice were less susceptible to bladder tumorigenesis. Additionally, UCHL3 was highly expressed in bladder cancer cells and associated with indicators of advanced clinicopathology. Conclusion In summary, we found that UCHL3 is amplified in bladder cancer and functions as a tumor promoter that enhances proliferation and migration of tumor cells in vitro and bladder tumorigenesis and progression in vivo. Furthermore, we revealed that UCHL3 stabilizes CTNNB1 expression, resulting in the activation of the oncogenic Wnt signaling pathway. Therefore, our findings strongly suggest that UCHL3 is a promising therapeutic target for bladder cancer.
first_indexed 2024-03-10T17:07:54Z
format Article
id doaj.art-77b0d8d306b94929b2993eeac723798f
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-03-10T17:07:54Z
publishDate 2023-09-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-77b0d8d306b94929b2993eeac723798f2023-11-20T10:45:18ZengBMCJournal of Translational Medicine1479-58762023-09-0121111610.1186/s12967-023-04311-3Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progressionTao Liu0Meng-Qi Fan1Xiao-Xiao Xie2Qi-Peng Shu3Xue-Hua Du4Lin-Zhi Qi5Xiao-Dong Zhang6Ming-Hui Zhang7Guang Shan8Run-Lei Du9Shang-Ze Li10Department of Urology, Zhongnan Hospital of Wuhan UniversityHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan UniversitySchool of Medicine, Chongqing UniversityHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan UniversityHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan UniversitySchool of Medicine, Chongqing UniversityHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan UniversityDepartment of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou UniversityDepartment of Urology, Renmin Hospital of Wuhan UniversityHubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan UniversitySchool of Medicine, Chongqing UniversityAbstract Background The catenin beta 1 gene (CTNNB1) plays a crucial role in the malignant progression of various cancers. Recent studies have suggested that CTNNB1 hyperactivation is closely related to the occurrence and development of bladder cancer (BCa). As a member of the deubiquitinating enzyme (DUB) family, ubiquitin C-terminal hydrolase L3 (UCHL3) is abnormally expressed in various cancers. In this study, we discovered that UCHL3 is a novel oncogene in bladder cancer, suggesting it is a promising target against bladder cancer. Methods We utilized CRISPR‒Cas9 technology to construct cell lines with UCHL3 stably overexpressed or knocked out. The successful overexpression or knockout of UCHL3 was determined using Western blotting. Then, we performed CCK-8, colony formation, soft agar and Transwell migration assays to determine the impact of the UCHL3 gene on cell phenotype. RNA-seq was performed with UCHL3-depleted T24 cells (established via CRISPR–Cas9-mediated genomic editing). We analyzed differences in WNT pathway gene expression in wild-type and UCHL3-deficient T24 cell lines using a heatmap and by gene set enrichment analysis (GSEA). Then, we validated the effect of UCHL3 on the Wnt pathway using a dual fluorescence reporter. We then analyzed the underlying mechanisms involved using Western blots, co-IP, and immunofluorescence results. We also conducted nude mouse tumor formation experiments. Moreover, conditional UCHL3-knockout mice and bladder cancer model mice were established for research. Results We found that the overexpression of UCHL3 boosted bladder cancer cell proliferation, invasion and migration, while the depletion of UCHL3 in bladder cancer cells delayed tumor tumorigenesis in vitro and in vivo. UCHL3 was highly associated with the Wnt signaling pathway and triggered the activation of the Wnt signaling pathway, which showed that its functions depend on its deubiquitination activity. Notably, Uchl3-deficient mice were less susceptible to bladder tumorigenesis. Additionally, UCHL3 was highly expressed in bladder cancer cells and associated with indicators of advanced clinicopathology. Conclusion In summary, we found that UCHL3 is amplified in bladder cancer and functions as a tumor promoter that enhances proliferation and migration of tumor cells in vitro and bladder tumorigenesis and progression in vivo. Furthermore, we revealed that UCHL3 stabilizes CTNNB1 expression, resulting in the activation of the oncogenic Wnt signaling pathway. Therefore, our findings strongly suggest that UCHL3 is a promising therapeutic target for bladder cancer.https://doi.org/10.1186/s12967-023-04311-3UCHL3Bladder cancerWnt signaling pathwayCTNNB1
spellingShingle Tao Liu
Meng-Qi Fan
Xiao-Xiao Xie
Qi-Peng Shu
Xue-Hua Du
Lin-Zhi Qi
Xiao-Dong Zhang
Ming-Hui Zhang
Guang Shan
Run-Lei Du
Shang-Ze Li
Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
Journal of Translational Medicine
UCHL3
Bladder cancer
Wnt signaling pathway
CTNNB1
title Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
title_full Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
title_fullStr Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
title_full_unstemmed Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
title_short Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
title_sort activation of ctnnb1 by deubiquitinase uchl3 mediated stabilization facilitates bladder cancer progression
topic UCHL3
Bladder cancer
Wnt signaling pathway
CTNNB1
url https://doi.org/10.1186/s12967-023-04311-3
work_keys_str_mv AT taoliu activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT mengqifan activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT xiaoxiaoxie activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT qipengshu activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT xuehuadu activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT linzhiqi activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT xiaodongzhang activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT minghuizhang activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT guangshan activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT runleidu activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression
AT shangzeli activationofctnnb1bydeubiquitinaseuchl3mediatedstabilizationfacilitatesbladdercancerprogression